Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. William Zucchi (Botucatu, Brazil), B. Evelyn Bueno De Morais (Botucatu, Brazil), T. Garcia (Botucatu, Brazil), L. Henrique Soares Machado (Botucatu, Brazil), A. Natalia Ribeiro Batista (Botucatu, Brazil), E. Aparecida Thome Franco (Botucatu, Brazil), I. Godoy (Botucatu, Brazil), S. Erico Tanni (Botucatu, Brazil). Eosinophils and different clusters in COPD patients.. 1077

Member's Comments

No comment yet.

Related content which might interest you: Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 The relationship between blood eosinophils and bacterial load in COPD patients Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Differences in responsiveness of blood neutrophils for fMLF indentify two distinct groups of COPD patients Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 The comparison of eosinophilic and non-eosinophilic  stable COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Characterization of lymphocyte subsets in the lungs of smokers and patients with COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003 Comparative characteristics of regulatory T cells populations between patients with bronchial asthma (BA) and COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Different prostanoid phenotypes in lung fibroblasts from patients with asthma and COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Expression of selected surface markers on macrophages in induced sputum from patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Neutrophils and spirometry changes in COPD patients treated with roflumilast Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016